1DpwC8F

Recommendations

Info

Suicide Risk Title Population Recommendation Screening for Suicide Risk General population No recommendation. Grade: I (Insufficient Evidence) Risk Assessment The strongest risk factors for attempted suicide include mood disorders or other mental disorders, comorbid substance abuse disorders, history of deliberate self-harm, and a history of suicide attempts. Deliberate self-harm refers to intentionally initiated acts of self-harm with a nonfatal outcome (including self-poisoning and self-injury). Suicide risk is assessed along a continuum ranging from suicidal ideation alone (relatively less severe) to suicidal ideation with a plan (more severe). Suicidal ideation with a specific plan of action is associated with a significant risk for attempted suicide. 58 Screening Tests There is limited evidence on the accuracy of screening tools to identify suicide risk in the primary care setting, including tools to identify those at high risk. The characteristics of the most commonly used screening instruments (Scale for Suicide Ideation, Scale for Suicide Ideation–Worst, and the Suicidal Ideation Questionnaire) have not been validated to assess suicide risk in primary care settings. Interventions Balance of Benefits and Harms Other Relevant USPSTF Recommendations There is insufficient evidence to determine if treatment of persons at high risk for suicide reduces suicide attempts or mortality. There is no evidence that screening for suicide risk reduces suicide attempts or mortality. There is insufficient evidence to determine if treatment of persons at high risk reduces suicide attempts or mortality. There are no studies that directly address the harms of screening and treatment for suicide risk. As a result, the USPSTF could not determine the balance of benefits and harms of screening for suicide risk in the primary care setting. The USPSTF has also made recommendations on screening for alcohol misuse, depression, and illicit drug use. These recommendations are available at http://www.uspreventiveservicestaskforce.org/. For a summary of the evidence systematically reviewed in making this recommendation, the full recommendation statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org/.
Syphilis (Pregnant Women) Title Population Recommendation Screening for Syphilis Infection in Pregnancy All pregnant women Screen for syphilis infection. Grade: A Screening Tests Nontreponemal tests commonly used for initial screening include: ●● ●● Venereal Disease Research Laboratory (VDRL) Rapid Plasma Reagin (RPR) Confirmatory tests include: ●● ●● Fluorescent treponemal antibody absorbed (FTA-ABS) Treponema pallidum particle agglutination (TPPA) 59 Timing of Screening Other Clinical Considerations Test all pregnant women at the first prenatal visit. Most organizations recommend testing high-risk women again during the third trimester and at delivery. Groups at increased risk include: ●● ●● ●● ●● ●● ●● Uninsured women Women living in poverty Sex workers Illicit drug users Those diagnosed with other sexually transmitted infections (STIs) Other women living in communities with high syphilis morbidity Prevalence is higher in southern U.S. and in metropolitan areas and in Hispanic and African American populations. Interventions Other Relevant USPSTF Recommendations The Centers for Disease Control and Prevention (CDC) recommends treatment with parenteral benzathine penicillin G. Women with penicillin allergies should be desensitized and treated with penicillin. Consult the CDC for the most up-to-date recommendations: http://www.cdc.gov/std/treatment/. Recommendations on screening for other STIs, and on counseling for STIs, can be found at http://www.uspreventiveservicestaskforce.org. For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents, please go to http://www.uspreventiveservicestaskforce.org.
Page 1 and 2:
The Guide to Clinical Preventive Se
Page 3:
The Guide to Clinical Preventive Se
Page 7 and 8:
Preface The U.S. Preventive Service
Page 9:
Selector (ePSS), available via PDA,
Page 12 and 13:
Hemochromatosis, Screening.........
Page 15:
Preventive Services Recommended by
Page 18 and 19:
Section 1: Preventive Services Reco
Page 20 and 21:
4 13 Asymptomatic adults with susta
Page 23 and 24: Abdominal Aortic Aneurysm Title Scr
Page 25 and 26: Aspirin for the Prevention of Cardi
Page 27 and 28: Bacterial Vaginosis in Pregnancy Ti
Page 29 and 30: Bladder Cancer Title Population Rec
Page 31 and 32: Breast Cancer (Preventive Medicatio
Page 33 and 34: Breastfeeding Title Primary Care In
Page 35 and 36: Cervical Cancer Title Screening for
Page 37 and 38: Chronic Kidney Disease Title Popula
Page 39 and 40: Cognitive Impairment Title Populati
Page 41 and 42: Coronary Heart Disease (Risk Assess
Page 43 and 44: Depression in Adults Title Populati
Page 45 and 46: Falls in Older Adults Title Populat
Page 47 and 48: Genital Herpes Time Screening for G
Page 49 and 50: Glaucoma Title Population Recommend
Page 51 and 52: Healthful Diet and Physical Activit
Page 53 and 54: Hemochromatosis Title Population Re
Page 55 and 56: Hepatitis C Virus Infection Title S
Page 57 and 58: HIV Infection Title Population Reco
Page 59 and 60: Impaired Visual Acuity in Older Adu
Page 61 and 62: Lipid Disorders in Adults Title Scr
Page 63 and 64: Menopausal Hormone Therapy Title Me
Page 65 and 66: Obesity in Adults Title Population
Page 67 and 68: Osteoporosis Title Screening for Os
Page 69 and 70: Peripheral Artery Disease Title Pop
Page 71 and 72: Sexually Transmitted Infections Tit
Page 73: Skin Cancer (Screening) Title Scree
Page 77 and 78: Tobacco Use in Adults Title Counsel
Page 79: Vitamin Supplementation to Prevent
Page 83 and 84: Blood Lead Levels in Children and P
Page 85 and 86: Congenital Hypothyroidism Title Scr
Page 87 and 88: Gonococcal Ophthalmia Neonatorum Ti
Page 89 and 90: High Blood Pressure (Children) Titl
Page 91 and 92: Illicit and Prescription Drug Use i
Page 93 and 94: Iron Deficiency Anemia (Supplementa
Page 95 and 96: Major Depressive Disorder in Childr
Page 97 and 98: Phenylketonuria (PKU) Title Populat
Page 99 and 100: Speech and Language Delay Title Pop
Page 101: Visual Impairment in Children Ages
Page 105: Immunizations for Adults and Childr
Page 109 and 110: Topics in Progress Each USPSTF reco
Page 111: Appendixes and Index
Page 114 and 115: Grade Definitions What the Grades M
Page 116 and 117: Grade Definitions Prior to May 2007
Page 118 and 119: David Grossman, M.D., M.P.H. Center
Page 120 and 121: Appendix C Acknowledgements AHRQ St
Page 122 and 123: Liaisons to the USPSTF Primary care
Page 124 and 125:
The Task Force does not explicitly
Page 126 and 127:
■■ ■■ Access the Electronic
Page 128 and 129:
Appendix E More Resources AHRQ’s
Page 130 and 131:
Healthy People 2020 Healthy People
Page 133 and 134:
Index 2-hour postload plasma (see D
Page 135 and 136:
Coronary Heart Disease (Risk Assess
Page 137 and 138:
*Illicit and Prescription Drug Use
Page 139:
Syphilis Infection (Pregnant Women)
Page 143 and 144:
The U.S. Preventive Services Task F
show all

1DpwC8F

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?